Press Releases

AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt

Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans faster. The company is partnering with Tuition.io, the leading platform for employee student loan contributions, to administer the program. As part of the benefit, AlloSource employees will receive monthly contributions to help pay down the principal of their student loans. According to Willis Towers Watson, only 4% of companies in the United States offer…

AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress

Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage Repair Society’s 14th World Congress on Wednesday, April 11 from 13:00-14:00 in the Almaty 3 Room. Dr. Vishal Mehta will present his 24-month clinical experience with ProChondrix in the knee. Dr. Mehta performed the first ProChondrix implantation in December of 2014 and will share his clinical experience with the product. “ProChondrix has been a valuable addition to my…

AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft

Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function. AlloSource launched ProChondrix in 2016 and developed a cryopreserved version to provide a longer shelf-life, while maintaining the high cellular viability of the product1. “ProChondrix CR demonstrates our commitment to innovation and our surgeon customers,” said Kerr…

AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory

Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with the International Space Station environmental surfaces” that was published today in Nature’s Scientific Reports. Manned space flights have always been accompanied by the human microbiome, which travels with the astronauts through the duration of the missions and remains on the International Space Station (ISS). Previous studies on the ISS have acknowledged and identified many of the microbes capable of surviving…

AlloSource Launches Placental Donation Program

Centennial, Colo. — December 20, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts that advance patient healing, today announced the launch of the AlloSource Placental Donation Program. This initiative provides the opportunity for women undergoing scheduled caesarean sections to collaborate with AlloSource and their doctor to facilitate the donation of placental tissue following delivery. AlloSource will work directly with physicians, hospitals, and expectant mothers who are interested in donating their placental tissue following an elective C-section. The first hospital AlloSource is partnering with on the initiative is Lutheran Medical Center in…

AlloSource Announces Raime Leeby Muhle As Chief Financial Officer

Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial Officer. With over 18 years of experience, her background spans from emerging high growth businesses to large and mature organizations. She has worked in a variety of industries including technology, distribution, manufacturing, and telecommunications. Leeby Muhle’s expertise in complex environments, as well as working cross-functionally, will help her lead the accounting, financial, and information technology…

American Heart Association Recognizes AlloSource For Workplace Health Achievements

Centennial, Colo. — December 5, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced it received recognition from the American Heart Association for promoting a workplace culture of health and well-being. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. AlloSource received Silver-level recognition for its health and wellness efforts. “Our role in healthcare gives us…

AlloSource Announces Bob Lay As Chief Operating Officer

Centennial, Colo. — November 7, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer. With over 20 years of experience in both finance and operations, Bob has a broad-based understanding of how each department within an organization impacts another. He has an extensive background working with businesses and medical device companies to conduct operational audits, improve processes and systems, and balance the needs of many departments to drive company…

AlloSource To Highlight AlloFuse Select CM Cellular AlloGraft Matrix At North American Spine Society Annual Meeting

Centennial, Colo. — October 24, 2017 — AlloSource, one of the nation’s largest providers of cellular, cartilage, bone, skin and soft-tissue allografts to advance patient healing in surgical procedures, will highlight AlloFuse® Select CM at the North American Spine Society Annual Meeting (NASS). AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to support the initiation and nurturing of bone growth, leading to consistent spinal fusion outcomes and delivering the benefits of autograft bone without the potential drawbacks. The product engages the body’s natural healing power and can be used in a variety of spinal, neurologic, and orthopedic procedures. “AlloFuse…

AlloSource President And CEO Thomas Cycyota Receives American Association Of Tissue Banks Award

Centennial, Colo. — October 10, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced that its President and Chief Executive Officer, Thomas Cycyota, received the Jeanne C. Mowe Distinguished Service Award from the American Association of Tissue Banks (AATB). The annual Jeanne C. Mowe Distinguished Service Award recognizes an individual who has made a significant contribution in tissue banking or transplantation, whether in research, education, or laboratory improvement, or who has served the Association or the field of…